Podcasts about Isaacs

Fresh off a $10 billion valuation, the direct-from-manufacturer online retailer Quince is on a hot streak. It's been testing physical retail with pop-ups and expanding into new categories, from furniture to caviar. But while the company had no shortage of sales, what it was lacking was a coherent brand story. Dakota Kate Isaacs, formerly a senior director at The Ordinary, started at Quince in February as the company's first head of brand strategy and narrative. Her goal has been to help Quince build an emotional connection with its customers, for reasons beyond just the low prices that attract them in the first place. Isaacs spoke with senior fashion reporter Danny Parisi at the Glossy E-commerce Summit in Miami this month to discuss what strategies she's been adopting to build those relationships. "My goal is not to create a new story for the brand, but [instead] to articulate the story to everyone," she said. "The narrative around Quince often gets condensed just to price, but the price isn't the story. The price is the result of the system, and the system is the story." To that end, Isaacs has been pushing for more initiatives, including a recent furniture pop-up in Los Angeles. Isaacs said pop-ups allow new categories like fragrance and wellness to be introduced in a more comprehensive, aesthetically cohesive way, with accompanying imagery and branding. For example, another recent pop-up for its fine jewelry category was held in a coffee shop in Manhattan. "I'm working to tell the true story of the business," Isaacs said. "What makes this business unique is the technology and the system behind the business

I recently chatted with author Darek Isaacs about his new novel, The Legendary Adventures of Doc Copper and the Mad Dash of Fire Face, published by Skyhorse Publishing. Drawing from his childhood summers spent living in Ohio, Isaacs infuses the story with high-octane dirt bike racing and dangerous adrenaline. He even shared the real-life inspiration behind the book's wild horse scenes—his own teenage "midnight runs" riding bareback on a cattle farm. The novel appeals to a broad spectrum of readers, from ages 12 to 75, by intentionally channeling the natural, rambunctious energy of youth into positive pursuits rather than squashing it. Written at a fast clip with section breaks instead of traditional chapters, the book cuts the downtime to keep the action constantly moving. It's a quick, gripping read that draws from his own travels through Mexico and Texas. Check out our full interview wherever you get podcasts.Thanks for listening!Kyler---PURCHASE: The Legendary Adventures of Doc Copper: And the Mad Dash of Fire Face

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, shot live at the American Diabetes Association (ADA) Scientific Sessions 2026 in New Orleans, Louisiana, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the latest major trial results like CONNECT, TRIUMPH, and TRANSCEND.To begin the episode, Isaacs and Bellini, discuss major highlights from ADA Scientific Sessions, focusing first on the landmark CONNECT trial evaluating continuous glucose monitoring (CGM) in people with type 2 diabetes who are not treated with insulin. They reflect on the evolution of CGM technology, from its early use primarily in type 1 diabetes to its expanding role in type 2 diabetes management, and explain why this trial represents an important step forward for patients who have historically had limited access to CGM.The hosts review the randomized controlled trial findings, emphasizing the significant improvements in glycemic outcomes, including a 1.6% reduction in A1c from baseline and an approximately 0.9% greater reduction compared with standard care. They also highlight the increase in time in range, with participants using CGM achieving roughly five additional hours per day in target glucose range. The magnitude of these findings is discussed as a practice-changing development, with the potential to influence future clinical guidelines and strengthen recommendations for CGM use among individuals with type 2 diabetes who are not using insulin.The discussion also explores the broader implications of the CONNECT trial for healthcare access and insurance coverage. The hosts note that randomized controlled trial evidence has historically played a key role in shaping standards of care and payer decisions, and they suggest that these results may help support wider adoption of CGM by demonstrating meaningful improvements in glucose control and patient outcomes.The conversation then shifts to emerging pharmacologic advances, with a focus on retatrutide, a novel triple agonist targeting GLP-1, GIP, and glucagon pathways. The hosts discuss new data showing substantial metabolic benefits in people with type 2 diabetes, including up to 17% weight reduction and nearly 2% A1c lowering. They highlight how these findings represent a major advancement in diabetes and obesity treatment, particularly as clinicians continue to see increasingly powerful effects from next-generation incretin-based therapies.Isaacs and Bellini explore how these therapies may reshape treatment strategies by allowing clinicians to tailor medication choices based on individual patient needs and goals. They discuss the importance of considering both glucose lowering and weight reduction effects, recognizing that some patients may benefit from significant weight loss while others may require a more balanced approach focused primarily on glycemic improvement.The hosts also address important unanswered questions surrounding the use of highly effective weight-loss medications, including appropriate treatment targets, the limitations of BMI as a measure, and the importance of preserving muscle mass and overall function. They emphasize the need to consider body composition, physical activity, resistance training, and patient characteristics—particularly in older adults or those at risk for frailty—when developing long-term treatment plans.The episode concludes with a reflection on the rapidly evolving landscape of diabetes care. The hosts highlight how advances in CGM technology and novel metabolic therapies are creating new opportunities to improve outcomes, personalize treatment approaches, and redefine the future management of people living with diabetes.Editors' Note: Isaacs reports disclosures with Dexcom, Abbott, Lilly, Novo Nordisk, Medtronic, Insulet, and others. Bellini reports disclosures with Abbott Diabetes Care, MannKind, Povention Bio, and others.

"Maybe It's Just Me" The indie rock outfit Lost Leaders were formed in 2011 by pals Byron Isaacs and Peter Cole. Isaacs' resume was already pretty full at the time, thanks to his work as the bassist for the Lumineers and playing with the Levon Helm Band and Ollabelle. If that doesn't sound busy enough, Isaacs has also recorded and performed with Bruce Springsteen, Roseanne Cash, Jackson Browne, Amy Helm, and Joan Baez. As for singer/guitarist Cole, his CV was pretty full as well, thanks to his tenure in Lava Baby, long-serving the New York jazz scene and working as a professional audio engineer. Cole and Isaacs have been pals since the late '90s, playing in bands like Slink and Lowdowners in Stereom, but Lost Leaders is where the two musicians really hit their artistic stride. With a handful of winning albums under their belts like Hungry Ghosts, Promises Promises and their self-titled debut album, Lost Leaders' work is redolent with harmonic dexterity, melodic muscle and rootsy bliss. Their latest effort is producing the full soundtrack and composing the original score for the indie film RUN, which stars Sarah Levy, Adam Palley and Chris Redd. By the way, the soundtrack features Amy Helm and Samantha Fish and it's just wonderful Lost Leaders are about to hit the road opening for The Wallflowers, but before they do, they had a chat with us. And here it is... https://byronisaacs.com www.bombshellradio.com www.stereoembersmagazine.com www.alexgreenbooks.com (http://www.alexgreenbooks.com) Stereo Embers Threads + IG + BLUESKY: @emberspodcast Email: editor@stereoembersmagazine.com

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! In this special episode, shot live at the American Diabetes Association (ADA) Scientific Sessions 2026 in Ner Orleans, Louisiana, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, are joined by Amit Gupta, MBBS, DNB, diabetologist, executive director of the Global Metabolic Health Alliance, and chair of the International Diabetes Federation (IDF) Education Committee, to discuss the state of diabetes care and treatment in India compared to the US.To begin the episode, Gupta introduces the mission of the IDF, highlighting its role as a worldwide federation of scientific societies and patient organizations focused on improving diabetes education, policy, advocacy, and access to care. The conversation explores how diabetes management differs across regions, emphasizing that while the underlying disease mechanisms and available therapies may be similar, access to medications, technologies, healthcare infrastructure, and education varies significantly between countries.Gupta discusses the impact of semaglutide becoming available as a generic therapy in India following patent expiration, describing how reduced costs have improved access to a medication previously limited by affordability barriers. The group considers how increased availability of GLP-1 receptor agonists may transform diabetes and obesity management, while also emphasizing that pharmacologic therapies alone cannot address the global metabolic health crisis. Gupta notes the importance of maintaining focus on long-term lifestyle changes, including nutrition, physical activity, and sustainable weight management, as essential components of comprehensive care.The discussion then shifts to diabetes education and the need for more individualized, patient-centered approaches. Gupta highlights that education must be adapted to regional and cultural contexts, explaining that the challenges faced by a person with diabetes in the United States, Africa, India, or other parts of the world may differ substantially, even though diabetes distress and the burden of daily decision-making are shared experiences. He emphasizes that access to technology, such as continuous glucose monitoring, does not eliminate the need for education and support.Isaacs, Bellini, and Gupta also address the growing challenge of misinformation online and the role of healthcare professionals in helping patients navigate unreliable sources of health information. Gupta explains that clinicians must approach misinformation constructively by providing evidence-based guidance rather than simply dismissing patients' beliefs, reinforcing the importance of translating scientific evidence into practical recommendations that patients can incorporate into their daily lives.The group further examines disparities in the availability of diabetes educators worldwide. Gupta notes that while some regions have established professional pathways for diabetes care and education specialists, many areas lack standardized training, recognition, or policy support to sustain these roles. He stresses that building effective diabetes education systems requires collaboration with policymakers to demonstrate the long-term benefits of structured education programs.The episode concludes with Gupta discussing his work developing a global consensus framework on lifestyle as the foundation of metabolic health. The conversation reinforces that advances in medications and technology must be paired with equitable access, effective education, and sustainable lifestyle interventions to reduce the global burden of diabetes and improve outcomes for people living with metabolic conditions.Editors' Note: Isaacs reports disclosures with Dexcom, Abbott, Lilly, Novo Nordisk, Medtronic, Insulet, and others. Bellini reports disclosures with Abbott Diabetes Care, MannKind, Povention Bio, and others. Gupta reports disclosures with Lilly, Abbott Diabetes, and the International Diabetes Federation.

A Warbler Said What? Inside It's Hard to be an Animal with Robert Isaacs Henry has lived a simple life and worked hard to avoid conflict and love. But while walking through Central Park on a blind date with Molly, Henry hears a warbler cuss. After that, he hears his roommate's Beta Fish speaking Shakespearean English. Then there's Gracie, the neighbor's Pomeranian and the park pigeons who all speak to him. Henry's convinced he's losing his mind. While trying to figure out his new superpower, Henry eavesdrops on some subway rats revealing the fact that there are bodies being dumped in the New York tunnels. Henry is shocked. Are these murder victims? Henry finally tells Molly his secret, and to his surprise, she wants to help him investigate. It's Hard to be an Animal is a laugh out loud debut novel that also weaves in a fun mystery, love and discovering courage. For more information on Robert, visit: hachettebookgroup.com/contributor/robert-isaacs For more about my K-9 books, visit: kathleendonnelly.com Sit. Stay. Read. is a proud part of the Authors on the Air Global Network.

A Warbler Said What? Inside It's Hard to be an Animal with Robert Isaacs Henry has lived a simple life and worked hard to avoid conflict and love. But while walking through Central Park on a blind date with Molly, Henry hears a warbler cuss. After that, he hears his roommate's Beta Fish speaking Shakespearean English. Then there's Gracie, the neighbor's Pomeranian and the park pigeons who all speak to him. Henry's convinced he's losing his mind. While trying to figure out his new superpower, Henry eavesdrops on some subway rats revealing the fact that there are bodies being dumped in the New York tunnels. Henry is shocked. Are these murder victims? Henry finally tells Molly his secret, and to his surprise, she wants to help him investigate. It's Hard to be an Animal is a laugh out loud debut novel that also weaves in a fun mystery, love and discovering courage. For more information on Robert, visit: hachettebookgroup.com/contributor/robert-isaacs For more about my K-9 books, visit: kathleendonnelly.com Sit. Stay. Read. is a proud part of the Authors on the Air Global Network.

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this special episode recorded live at the American Diabetes Association (ADA) Scientific Sessions 2026 in New Orleans, Louisiana, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, welcome Trang Ly, PhD, MBBS, senior vice president and Chief Medical Officer at Insulet, to discuss the continued evolution of automated insulin delivery (AID) technology and emerging developments across the Omnipod platform. To begin the episode, Ly first reviews updates to Omnipod 5, focusing on enhancements aimed at increasing time in automated mode and improving glucose management. She explains that user feedback identified opportunities to support lower glucose targets and reduce interruptions related to system alerts. Data from real-world evidence and computer simulations suggest that lowering the glucose target from 110 to 100 mg/dL may lead to meaningful improvements in time in range and time in tight range without increasing hypoglycemia risk.The group discusses early clinical experience with these enhancements, including findings from users who transitioned to the updated system. Ly highlights that even a highly engaged population already using lower targets experienced additional improvements, including a 2% increase in time in range and a 5% increase in time in tight range over a short period of use. The conversation emphasizes the importance of making these improvements broadly available rather than waiting for routine follow-up visits, particularly given the potential benefits without additional safety concerns.The discussion then turns to Omnipod 6, with Ly sharing newly presented clinical trial data evaluating the next-generation system. She describes the study design, which enrolled users already achieving strong glycemic control on Omnipod 5 and assessed whether further intensification through algorithm improvements could safely provide additional benefits. The results demonstrated a 4% improvement in time in range and up to a 7% increase in time in tight range, with particularly notable improvements among individuals with type 1 diabetes aged 14 years and older.Ly explains that Omnipod 6 builds on previous technology through changes to the core algorithm, allowing the system to deliver more insulin when users do not bolus consistently. The panel explores how this approach may reduce the burden of diabetes management by allowing the algorithm to take on more responsibility while maintaining glycemic control. They discuss the potential psychological benefits of reducing the daily demands placed on people with diabetes, especially as sensor accuracy and automation continue to improve.The conversation also highlights future opportunities for AID in type 2 diabetes. Ly shares early feasibility data from a fully closed-loop system designed specifically for individuals with type 2 diabetes, emphasizing its simplified approach without requiring traditional pump programming or meal bolusing. In this study, participants experienced improvements in time in range, demonstrating the potential for automated insulin delivery to reach broader populations.Isaacs and Bellini discuss the need to reconsider barriers to insulin pump adoption in type 2 diabetes and recognize AID as an accessible option for patients who may benefit. Ly emphasizes that technology should support people across different levels of engagement, offering both highly customizable systems for those seeking intensive management and simpler automated approaches for those looking to reduce daily treatment demands.The episode concludes with a discussion of the future of diabetes technology, including improved connectivity, expanded device flexibility, and continued integration with complementary therapies such as GLP-1 receptor agonists. Ly underscores that innovation should not only improve clinical outcomes but also reduce the burden of care, allowing people with diabetes to spend less time managing their condition and more time living their lives.Editors' Note: Isaacs reports disclosures with Dexcom, Abbott, Lilly, Novo Nordisk, Medtronic, Insulet, and others. Bellini reports disclosures with Abbott Diabetes Care, MannKind, Povention Bio, and others. Ly reports a disclosure with Insulet.References1: Insulet. Insulet Reveals New Data Supporting Breakthrough Omnipod 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care. June 6, 2026. Accessed June 7, 2026. https://investors.insulet.com/news/news-details/2026/Insulet-Reveals-New-Data-Supporting-Breakthrough-Omnipod-6-and-Fully-Closed-Loop-AID-Systems-Designed-to-Improve-Outcomes-Reduce-Effort-and-Unlock-Barriers-to-Care/default.aspx

Macey Isaacs jokes about miscarriages in "Funny AF with Kevin Hart Episode 2".

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this special episode recorded on-site at the American Diabetes Association (ADA) Scientific Sessions 2026 in New Orleans, Louisiana, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, welcome Dr. Eugene Wright Jr., MD, the principal of Wright Health Care Solutions and a consulting associate in the department of medicine at Duke University Medical Center, to discuss the development of the ADA scientific statement on diabetes technology implementation in primary care. To begin the episode, Wright reflects on his career as an internist caring for patients with diabetes across diverse settings, including underserved communities where patients often faced significant barriers to accessing care. He describes how his experiences challenged assumptions about which patients would benefit from diabetes technology, noting that many under-resourced patients demonstrated strong engagement and improved self-management when given access to tools such as continuous glucose monitoring (CGM).The discussion focuses on the origins of the ADA scientific statement, which emerged from efforts to identify and overcome barriers limiting the adoption of diabetes technology in primary care. Wright explains that while diabetes technology has demonstrated significant benefits in improving outcomes and patient behaviors, implementation has remained slow in the settings where most people with diabetes receive care. The statement brought together key stakeholders, including clinicians, pharmacists, diabetes care and education specialists, patient representatives, and other experts, to develop practical strategies addressing policy, insurance, workflow, and clinical challenges.Isaacs, Bellini, and Wright explore how CGM can be successfully integrated into primary care by shifting the focus from simply providing access to using data effectively. Wright emphasizes that CGM and ambulatory glucose profile (AGP) reports allow clinicians to transform complex glucose data into actionable insights, helping identify patterns that may not be captured through A1C measurements or traditional glucose monitoring. The group discusses how CGM enables clinicians to ask better questions, uncover barriers to treatment, and engage patients in collaborative conversations without judgment.The hosts highlight the importance of building sustainable workflows, including preparing AGP reports before visits, assigning responsibilities across the care team, and identifying technology champions within practices. Wright explains that successful implementation requires recognizing the unique needs and resources of each primary care setting rather than applying a single model. They discuss the role of telehealth, clinical pharmacists, medical assistants, and other team members in supporting CGM initiation, interpretation, and ongoing management. The conversation also addresses how partnerships with technology manufacturers can simplify onboarding, training, troubleshooting, and patient support.The discussion then expands to insulin pumps and automated insulin delivery systems, with the group noting how advances in technology have reduced complexity and made these therapies more accessible for people with type 2 diabetes. Wright describes how newer systems can help reduce the daily burden of diabetes management by automating adjustments and supporting patients in achieving their goals. The hosts emphasize that diabetes care should move beyond focusing only on glucose metrics and instead consider the lived experience of patients, including the constant decision-making and emotional burden associated with managing diabetes.The episode concludes with a broader call to action for expanding access to diabetes technology across all healthcare settings. Wright emphasizes that many patients do not have access to endocrinology care but still deserve the benefits of modern diabetes tools. The scientific statement represents the beginning of an ongoing effort to improve implementation, strengthen collaboration among stakeholders, and ensure that diabetes technology reaches all patients who can benefit from it.Editors' Note: Isaacs reports disclosures with Dexcom, Abbott, Lilly, Novo Nordisk, Medtronic, Insulet, and others. Bellini reports disclosures with Abbott Diabetes Care, MannKind, Povention Bio, and others. Wright Jr. reports disclosures with Abbott Diabetes, Bayer AG, Boehringer Ingelheim, Lilly, and Sanofi.ReferencesSection 7: Diabetes technology. Diabetes Obesity and Cardiometabolic CARE. Published online March 23, 2026. doi:10.2337/doc26-a007

·      What are the primary roadblocks for Abrahams and Isaacs to accomplishing the acceleration of the next generation?·      What is the difference between giving honor and being controlled?·      What is the price of isolation?These questions are answered in this insightful podcast by Pastor John Nuzzo based on his book The Acceleration Mandate.  The best roadblock is the one you miss!  The best pain is the one you never experience!  As you listen to this message, you will learn how to avoid the pitfalls that will slow you down.  God is turning the hearts of the fathers to the children and the children to the fathers.  When generations unite, it accelerates the Kingdom of God.  Let's remain undivided in church and life relationships so that Jesus can be glorified and the Kingdom of God can expand.  ENCOUNTER CONFERENCE is a 3-day annual youth conference designed to create environments for believers to have an encounter with God so that our region is transformed for the Kingdom.  June 17 – 19, get your students, youth group, and children currently in grades 7-12 to Victory Family Church.  It will transform their lives, and they will have a blast doing it!  Only $59 per person.  Register HERE.The Acceleration Mandate by Pastor John Nuzzo is available wherever books are sold and can be also found HERE.

A dash of mystery, a sparkle of magic, and all things cozy! Elle interviews fellow cozy authors in this bookish podcast from Authors on the Air. Today on the podcast, meet Robert Isaacs, author of It's Hard to Be An Animal! Elle and Robert talk about the wide range of possibilities in animal conversation, what accents make for the most amusing villains, the similarities between writing books and performing music, and more. Happy listening! Robert's Bio: Robert Isaacs has survived an eventful life. He has escaped an angry hippo in the Okavango Delta, dodged tear gas on the Mount of Olives, roasted marshmallows over cooling lava in the Guatemalan highlands, and been run over by a boat off the west coast of Australia. In his youth he supported himself as a juggler and unicyclist on the streets of San Francisco before turning to music; over the course of thirty years he conducted everywhere from Carnegie Hall to the Cook Islands, released a dozen CDs, and earned a Grammy nomination. It's Hard to Be an Animal is his first novel. Find Robert and His Books Online: https://www.hachettebookgroup.com/contributor/robert-isaacs/ ~~~ Elle's Bio: Elle Hartford writes cozy mystery with a fairy tale twist. The award-winning first book in her Alchemical Tales series, Beauty and the Alchemist, finds amateur sleuth Red mixed up with murderous beasts and moody beauties, and a set of missing books besides! Elle has also written two spin-off series, the cozy fantasy-goes-to-the-beach Marine Magic series as well as Pomegranate Cafe Romance. For other writers and authors looking into “wide” indie publishing, check out the Beyond Writing blog (ellehartford.substack.com) with how-tos, resources, and back episodes of the Cozy Alchemy podcast. Find Elle Online: https://ellehartford.com

A dash of mystery, a sparkle of magic, and all things cozy! Elle interviews fellow cozy authors in this bookish podcast from Authors on the Air. Today on the podcast, meet Robert Isaacs, author of It's Hard to Be An Animal! Elle and Robert talk about the wide range of possibilities in animal conversation, what accents make for the most amusing villains, the similarities between writing books and performing music, and more. Happy listening! Robert's Bio: Robert Isaacs has survived an eventful life. He has escaped an angry hippo in the Okavango Delta, dodged tear gas on the Mount of Olives, roasted marshmallows over cooling lava in the Guatemalan highlands, and been run over by a boat off the west coast of Australia. In his youth he supported himself as a juggler and unicyclist on the streets of San Francisco before turning to music; over the course of thirty years he conducted everywhere from Carnegie Hall to the Cook Islands, released a dozen CDs, and earned a Grammy nomination. It's Hard to Be an Animal is his first novel. Find Robert and His Books Online: https://www.hachettebookgroup.com/contributor/robert-isaacs/ ~~~ Elle's Bio: Elle Hartford writes cozy mystery with a fairy tale twist. The award-winning first book in her Alchemical Tales series, Beauty and the Alchemist, finds amateur sleuth Red mixed up with murderous beasts and moody beauties, and a set of missing books besides! Elle has also written two spin-off series, the cozy fantasy-goes-to-the-beach Marine Magic series as well as Pomegranate Cafe Romance. For other writers and authors looking into “wide” indie publishing, check out the Beyond Writing blog (ellehartford.substack.com) with how-tos, resources, and back episodes of the Cozy Alchemy podcast. Find Elle Online: https://ellehartford.com

April 25, 2026 - Equipped 2026 - Day 3 - 1:15 PM Session In this episode we unpack Hebrews 11 and ask the question: why is Abraham called the father of our faith? Using Genesis, Romans, and Hebrews as touchstones, the speaker explores Abraham not only as a literal progenitor but as a spiritual model whose life teaches us how to live by faith. Guests Jett and Luke deliver reflections that frame Abraham's life as a pattern to follow — three specific “footprints” are highlighted: the footprint of trust (obeying God without a blueprint), the footprint of a traveler (living as temporary residents in tents while seeking a heavenly city), and the footprint of sacrifice (willingness to surrender what we love most, exemplified by Abraham's offering of Isaac). The episode references key scriptures (Hebrews 11:8–19, Romans 4, Genesis 12 & 15, John 14:3, Philippians 3:20, 1 Corinthians 15:58) and translates those passages into practical application: examining modern “Isaacs” (idols like phones, social media, jobs, hobbies), reconsidering where we set our roots, and embracing baptism and a pilgrim mentality. The sermon challenges listeners to trade earthly certainty for God's presence and to live visibly as people seeking a better country. Listeners can expect pastoral teaching, personal illustrations, and a clear invitation to evaluate their spiritual residency. The episode closes with gratitude to Jett, Luke, their parents and congregations, and a reminder of upcoming small-group sessions and panels for further discussion. Duration 11:06

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the recent FDA approval of MannKind's inhaled insulin Afrezza for pediatric patients aged 6 years and older with both type 1 and type 2 diabetes, describing the decision as a major milestone in diabetes therapeutics and the first expansion of the therapy beyond adults. The episode centers on the clinical implications of the approval, the pharmacologic advantages of inhaled insulin, and the practical considerations surrounding implementation in pediatric care settings.The hosts review findings from the INHALE-1 trial, which enrolled 230 pediatric participants aged 4 to 17 years and compared inhaled insulin used alongside basal insulin with standard multiple daily injection (MDI) therapy over 56 weeks. Bellini emphasizes that the study achieved its primary objective of demonstrating glycemic outcomes comparable to traditional insulin regimens, noting that insulin studies are generally designed to establish equivalence rather than superiority. Beyond similar glycemic control, the hosts highlight several clinically meaningful secondary observations, including stable BMI among participants receiving inhaled insulin compared with weight gain in the MDI cohort, increased treatment satisfaction reported by both adolescents and parents of younger children, comparable hypoglycemia rates, and the absence of new safety concerns. Bellini also notes that no decline in lung function was observed among participants using inhaled insulin, despite historical concerns surrounding pulmonary safety with inhaled therapies.A major focus of the discussion is the physiologic pharmacokinetic profile of Afrezza, which Isaacs characterizes as the most physiologic insulin currently available. She explains that inhaled insulin demonstrates measurable activity within approximately 12 minutes, peaks within 35 to 45 minutes, and clears the bloodstream in roughly 90 minutes. The hosts contrast this with subcutaneous rapid-acting insulin analogs, including ultra-rapid formulations, which retain a prolonged “tail” of insulin activity that can increase hypoglycemia risk. Isaacs and Bellini suggest that the shorter duration of inhaled insulin may reduce the cycle of overtreating hypoglycemia and subsequent rebound hyperglycemia, thereby potentially contributing to the absence of weight gain observed in the trial. Bellini further emphasizes that the rapid onset and offset of inhaled insulin restore some of the flexibility and spontaneity often lost in intensive insulin therapy, particularly around meal dosing and correction strategies.The conversation also situates inhaled insulin within the broader framework of individualized diabetes management and the ADA Standards of Care. Isaacs stresses that the approval should not be viewed as competing with automated insulin delivery (AID) systems, but rather as expanding patient choice. The hosts discuss how inhaled insulin may be especially valuable for individuals who do not wish to wear insulin pumps, desire periodic breaks from technology, or want to reduce the burden of injections. Isaacs additionally highlights the growing prevalence of pediatric type 2 diabetes and notes that, despite advances in incretin-based therapies, many youth still require insulin therapy. In that context, the possibility of pairing inhaled mealtime insulin with emerging once-weekly basal insulin formulations and GLP-1 receptor agonists is presented as a potentially transformative strategy for minimizing injection burden.Bellini and Isaacs also address practical implementation challenges within school settings. Because inhaled insulin acts rapidly, Bellini notes that administration timing may need to shift from the nurse's office to the cafeteria environment to avoid hypoglycemia if meals are delayed. At the same time, both hosts recognize that the flexibility of postprandial dosing could offer advantages for children with inconsistent eating patterns or concerns about privacy surrounding insulin administration. They further discuss the utility of inhaled insulin for rapid glucose corrections, noting that additional doses can be administered far sooner than with traditional injected rapid-acting insulin.The episode concludes with discussion of anticipated affordability initiatives from MannKind Corporation, including bridge programs designed to improve early access and reduce financial barriers to therapy. Isaacs and Bellini commend the company's efforts to secure pediatric approval and express optimism that broader availability of inhaled insulin will expand individualized treatment options, improve patient satisfaction, and enhance quality of life for children and adolescents living with diabetes.Editors' Note: Isaacs reports disclosures with Dexcom, Abbott, Lilly, Novo Nordisk, Medtronic, Insulet, and others. Bellini reports disclosures with Abbott Diabetes Care, MannKind, Povention Bio, and others.References1: HOLDER

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss several major developments in diabetes technology and obesity therapeutics, beginning with Abbott's announcement that its dual glucose-ketone monitoring systems, Libre Duo and Libre Duo 10 Day, have received CE mark approval in Europe. The hosts describe the devices as the first continuous glucose-ketone monitors capable of simultaneously measuring glucose and ketone levels through a single wearable sensor, with real-time ketone monitoring intended to identify rising risk for diabetic ketoacidosis (DKA). Bellini explains the rationale for separate 15-day adult and 10-day pediatric sensors, noting higher sensor failure rates and greater activity levels in children. Both hosts emphasize the potential clinical significance of continuous ketone monitoring, particularly for individuals with type 1 diabetes (T1D) using insulin pumps, where interruptions in insulin delivery can rapidly precipitate DKA.The discussion further explores how continuous ketone monitoring may expand the safe use of SGLT2 inhibitors in people with T1D and other high-risk populations. Bellini highlights concerns surrounding euglycemic DKA associated with SGLT2 inhibitor therapy and suggests that continuous ketone data could help clinicians identify susceptible individuals earlier, potentially enabling safer and more individualized dosing strategies. Isaacs underscores the limitations of current ketone testing methods, particularly urine ketone testing, which she characterizes as outdated and insufficient for modern diabetes management. The hosts also review additional patient populations that may benefit from continuous ketone monitoring, including individuals with recurrent DKA, pediatric patients with highly variable glycemic patterns, and hospitalized patients at elevated risk for ketosis due to prolonged fasting or treatment interruptions.Isaacs and Bellini also consider practical questions surrounding implementation, including reimbursement, cost, workflow integration, and compatibility with automated insulin delivery systems. They discuss whether continuous ketone monitoring could eventually become standard of care in T1D and debate the broader implications of widespread ketone data availability, including potential consumer interest outside traditional diabetes populations. Both hosts stress the importance of prioritizing access for patients at highest risk for DKA while acknowledging that broader adoption could reshape diabetes monitoring paradigms similarly to the evolution of continuous glucose monitoring.The episode then turns to recent reports involving Dexcom sensors that were reportedly stolen after being removed from the manufacturing process for quality concerns. Bellini explains that some of the affected sensors may not have completed sterility and quality assurance procedures before entering secondary markets. The hosts caution clinicians to review affected lot numbers and encourage ongoing vigilance until additional information becomes available. They also discuss the challenges of communicating recalls and safety alerts directly to patients, particularly for users relying on standalone receivers that may not connect to cloud-based notification systems.Finally, Isaacs and Bellini review newly released topline results from the phase 3 TRIUMPH-1 trial evaluating retatrutide, Lilly's investigational triple agonist targeting GLP-1, GIP, and glucagon receptors. Bellini summarizes findings demonstrating substantial weight reduction among adults with obesity or overweight without diabetes, including mean weight loss exceeding 28% at 80 weeks and continued weight reduction through 104 weeks without evidence of plateau. The hosts note that nearly half of participants achieved at least 30% weight loss, approaching outcomes historically associated with bariatric surgery. They also highlight low discontinuation rates and discuss the implications of future TRIUMPH studies evaluating retatrutide in patients with type 2 diabetes and cardiovascular disease. Isaacs concludes that the emerging data signal a transformative shift in obesity treatment, with pharmacologic therapies increasingly approaching surgical efficacy and potentially reshaping long-term obesity management strategies.Editors' Note: Isaacs reports disclosures with Dexcom, Abbott, Lilly, Novo Nordisk, Medtronic, Insulet, and others. Bellini reports disclosures with Abbott Diabetes Care, MannKind, Povention Bio, and others.

April 24, 2026 - Equipped 2026 - Day 2 - 3:30 PM Session This lectureship sermon walks through Genesis chapters 15–17, exploring how God's promises are revealed and fulfilled in the lives of Abram/Abraham, Sarai/Sarah, Hagar, Ishmael and the promised son Isaac. Delivered by a minister at a Christian lectureship (no guest speakers), the message focuses on biblical-history, covenant theology, and practical application for believers today. Genesis 15 is presented as a chapter of assurance: Abram's fear about being childless, God's repeated promise (look to the stars), and the covenant-ceremony with divided animals and the smoking oven/burning torch that confirms God's presence and sworn commitment. The preacher emphasizes that God is our shield and exceedingly great reward, and that past fulfillments of promise (culminating in Christ) give us confidence in future promises. Genesis 16 examines the danger of human attempts to "help" God: Sarai's plan to use Hagar, the painful consequences of that decision, Hagars flight and encounter with the angel of the Lord, and the birth and future character of Ishmael. The sermon warns that planning for God reveals a lack of faith, produces dissatisfaction, and ultimately fails to achieve Gods intended purpose. Genesis 17 highlights the renewal and clarification of God's covenant: Abram's name becomes Abraham, Sarai's name becomes Sarah, the covenant sign of circumcision is commanded (on the eighth day), and the promise of Isaacs coming is made explicit. The speaker notes the wisdom of the eighth-day command (medical context of clotting/prothrombin) and commends Abraham's prompt obedience, while noting God's broader mercy toward Ishmael. Key takeaways and applications: God's promises can carry us through deep fears; they do not require our feeble adjustments; and they point to a bright future founded on Gods faithfulness and oath (Hebrews 6). Listeners are encouraged to trust God's timing, rely on His presence, and find hope in the fulfilled and yet-to-be-fulfilled promises revealed throughout Scripture. Duration 37:26

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this special in-studio episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, reflect on major themes and anticipated developments ahead of the upcoming American Diabetes Association (ADA) Scientific Sessions 2026.The discussion opens with Bellini congratulating Isaacs on receiving the ADA Outstanding Educator in Diabetes Award, prompting a conversation centered on Isaacs' forthcoming presentation, “Behind Every Number Is a Story: Transforming Diabetes Care and Education through Technology and Human Connection.” Isaacs reflects on the rapid evolution of diabetes technology over the last decade, from limited continuous glucose monitoring (CGM) access and the emergence of early automated insulin delivery (AID) systems to the integration of artificial intelligence into diabetes care, while emphasizing that successful care remains grounded in human connection and individualized patient experiences.The hosts then preview several therapeutic areas expected to dominate discussion at ADA, particularly the expanding pipeline of incretin-based therapies. Bellini and Isaacs discuss growing excitement surrounding GLP-1, GIP, and glucagon receptor agonists, including anticipated data from triple agonist agents such as retatrutide and emerging oral therapies like orforglipron. They highlight the significance of improved weight-loss efficacy in people with type 2 diabetes (T2D), broader cardiometabolic applications, and the increasing importance of treatment accessibility and affordability. The conversation also explores the expanding role of these therapies in addressing cardiovascular disease, chronic kidney disease, sleep apnea, osteoarthritis, and other obesity-related comorbidities.Technology advancements represent another major focus of the episode. Isaacs and Bellini discuss new CGM-driven insulin titration tools, including Dexcom's Smart Basal feature, designed to address therapeutic inertia among people with T2D using basal insulin. They also examine the growing role of CGM in broader patient populations and discuss evolving ADA recommendations supporting CGM access for any individual likely to benefit from the technology. The hosts express particular enthusiasm for the anticipated arrival of continuous ketone monitoring, including dual glucose-ketone sensors, and consider how these devices may transform diabetic ketoacidosis prevention and patient education, particularly for individuals with type 1 diabetes (T1D).The conversation also highlights continued innovation in insulin delivery systems and connected diabetes devices. Isaacs and Bellini discuss progress toward fully closed-loop AID systems, including ongoing studies evaluating meal-unannounced insulin delivery in T2D. They review emerging insulin pump technologies from Medtronic, including updates to the MiniMed platform and the integration of connected insulin pen systems with real-time CGM data through the MiniMed Go app. The hosts emphasize the importance of preserving therapeutic choice for people who prefer injections over pump therapy or who seek temporary alternatives to wearable devices.Toward the conclusion of the episode, both hosts preview their own ADA presentations. Isaacs discusses an upcoming session on inhaled insulin that will use simulated patient scenarios to explore shared decision-making and individualized therapy selection. Bellini highlights her session focused on skin complications related to diabetes technologies, including allergic reactions and adhesive-related challenges that can interfere with sustained device use. Together, they underscore the importance of addressing practical barriers to technology adoption while continuing to expand therapeutic and technological options for people living with diabetes.Editors' Note: Isaacs reports disclosures with Dexcom, Abbott, Lilly, Novo Nordisk, Medtronic, Insulet, and others. Bellini reports disclosures with Abbott Diabetes Care, MannKind, Povention Bio, and others.

¿Qué nos dice un RÍO sobre quiénes somos? Juan Luis Mejía Arango nos invita a seguir el río Cauca desde su nacimiento en el macizo colombiano hasta su desembocadura, pero no por sus aguas sino por los POEMAS que lo han cantado a lo largo de cinco siglos. El viaje empieza en quechua, con el poeta yanakuna Fredy Chikangana. Pasa por los relatos de viajeros del siglo XIX —como el sueco Carl August Gosselman, que describió una balsa lanzada a toda velocidad por las gargantas del Cauca antioqueño— y por la frustrada ilusión de hacer navegable ese tramo, que ni siquiera Agustín Codazzi consideró viable. Llega al Valle del Cauca con la visión bucólica de Jorge Isaacs en María, pero también con un poema feroz del mismo Isaacs contra los caucanos que le arrebataron su hacienda. También leemos al Cauca en los poemas del gran León de Greiff, que, al llegar en 1925 a trabajar como contabilista del ferrocarril troncal de Occidente en BOLOMBOLO, se ve liberado de la rutina paramuna de Bogotá. Y en la Sata del Cauca del poeta Jaime Jaramillo Escobar (X-504): “Yo tuve una larga conversación con el río Cauca y me lo dijo todo, todo lo mismo que hubiera podido decirme el Magdalena, pero el río Cauca me puso la mano en el hombro y me habló al oído”. JUAN LUIS MEJÍA ARANGO (Medellín, 1951) es abogado, escritor e investigador. Fue director de la Biblioteca Nacional de Colombia, director de la Biblioteca Pública Piloto de Medellín, presidente de la Cámara Colombiana del Libro, secretario de Educación de Medellín, ministro de Cultura de Colombia y rector de la Universidad EAFIT durante 16 años (2004-2020). Es miembro correspondiente de la Academia Colombiana de la Lengua. Apoya nuestra labor educativa: @epmestamosahi

For today’s Unplugged we are joined live in studio by Fagrie Isaacs, he’s a celebrated South African soul and R&B singer, songwriter, and producer from Strandfontein, Cape Town. Often referred to as Cape Town’s own "Luther Vandross" due to his deep, velvety vocal tone, he has been a prominent fixture in the South African music landscape for nearly 35 years. Views and News with Clarence Ford is the mid-morning show on CapeTalk. This 3-hour long programme shares and reflects a broad array of perspectives. It is inspirational, passionate and positive. Host Clarence Ford’s gentle curiosity and dapper demeanour leave listeners feeling motivated and empowered. Known for his love of jazz and golf, Clarrie covers a range of themes including relationships, heritage and philosophy. Popular segments include Barbs’ Wire at 9:30am (Mon-Thurs) and The Naked Scientist at 9:30 on Fridays. Thank you for listening to a podcast from Views & News with Clarence Ford Listen live on Primedia+ weekdays between 09:00 and 12:00 (SA Time) to Views and News with Clarence Ford broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/erjiQj2 or find all the catch-up podcasts here https://buff.ly/BdpaXRn Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567See omnystudio.com/listener for privacy information.

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss a slew of advances in diabetes technology and treatments, starting with the US Food and Drug Administration (FDA)'s recent approval of the Tandem automated insulin delivery system for use during pregnancy in individuals with type 1 diabetes. The conversation centers on findings from the CIRCUIT trial, which demonstrated significant improvements in time in range among pregnant patients, a population historically challenging to manage because of stringent glycemic targets. Isaacs and Bellini review practical considerations from the study, including the use of continuous sleep mode to target tighter glucose ranges and proactive optimization of basal rates, correction factors, and carbohydrate ratios to improve outcomes. They emphasize that FDA approval now allows clinicians and manufacturers to openly discuss evidence-based best practices for pregnancy management using automated insulin delivery systems.The hosts also highlight the importance of clinician comfort with aggressive insulin automation during pregnancy, noting that increased basal modulation, suspensions, and automated adjustments should be expected as physiologic insulin needs fluctuate throughout gestation. Bellini stresses the importance of reducing patient burden while maintaining intensive glycemic management, tying this theme into Tandem's newly announced compatibility with the Dexcom G7 15-day sensor. Both hosts note strong patient enthusiasm for extending sensor wear time, framing reduced device maintenance as an important quality-of-life improvement even when the practical change appears modest.The discussion then shifts to immunotherapy in type 1 diabetes, focusing on the expanded approval of teplizumab to include children as young as 1 year old for delaying progression from stage 2 to stage 3 disease. Isaacs and Bellini underscore how broader eligibility may strengthen adoption of autoantibody screening among relatives of patients with type 1 diabetes. They review evidence showing that screening substantially lowers rates of diabetic ketoacidosis at diagnosis and discuss the broader clinical significance of delaying symptomatic disease onset, even when delays are shorter than the median duration reported in trials. The hosts note that many families value the possibility of a more gradual transition into insulin dependence, often requiring only minimal insulin therapy initially rather than presenting with severe metabolic decompensation.The conversation also addresses ongoing regulatory developments surrounding teplizumab for newly diagnosed stage 3 type 1 diabetes. Although the anticipated expedited review pathway has been withdrawn, the hosts remain optimistic about eventual approval, citing encouraging data and the growing role of precision medicine approaches in identifying patients most likely to benefit from immune intervention.To conclude the episode, Isaacs and Bellini examine a post hoc analysis from the SURMOUNT-5 trial comparing tirzepatide and semaglutide in adults with obesity and prediabetes. They discuss findings showing high rates of reversion to normoglycemia in both treatment groups, with tirzepatide demonstrating greater efficacy overall. The hosts frame these data within the broader movement to reconceptualize prediabetes as an earlier stage of type 2 diabetes and cardiovascular disease risk rather than a benign precursor state. They emphasize the potential value of earlier therapeutic intervention to prevent progression and reduce long-term cardiometabolic complications while also acknowledging the importance of maintaining multiple treatment options because of variability in medication tolerability and patient response.Editors' Note: Isaacs reports disclosures with Dexcom, Abbott, Lilly, Novo Nordisk, Medtronic, Insulet, and others. Bellini reports disclosures with Abbott Diabetes Care, MannKind, Povention Bio, and others.References1: Tandem Diabetes Care. Tandem Diabetes Care's Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes. April 27, 2026. Accessed May 8, 2026. https://investor.tandemdiabetes.com/news-releases/news-release-details/tandem-diabetes-cares-control-iq-automated-insulin-delivery2: Sanofi. Press Release: Sanofi's Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children. April 22, 2026. Accessed May 8, 2026. https://www.sanofi.com/en/media-room/press-releases/2026/2026-04-22-05-05-00-32786503: Galindo RJ, Aronne LJ, Horn DB, et al. Reversion to normoglycemia with tirzepatide vs semaglutide in participants with obesity and prediabetes: a post hoc analysis of SURMOUNT-5. J Endocrinol Invest. Published online April 20, 2026. doi:10.1007/s40618-026-02895-3

Linda Isaacs and I have a somewhat rocky history. But we have come to realize that we were both at fault in our actions and that is one of the reasons why I decided to have her in the WUW studio. Linda is running for Judge Executive of Jackson County. The What's up World Podcast is not for the faint of heart. In this studio we bring you guests from all walks of life. And we always root for the underdog. In your face, unapologetic and real. There's no preset questions or made up stories on this Podcast, just unscripted conversations that will leave you wanting more.   The WUW Podcast is brought to you by these great sponsors:  Vickers Tile & More Big Hill JEEP Club G&R Farms Sip Station  If you would like to sponsor an episode of the Podcast, please contact Danny at whatsupworld01@yahoo.com Sponsorships are just $25 a month. Special discount for multiple months.   

Film critic Bruce Isaacs stops by and delivers a verdict on the Michael Jackson biopic that cuts right through all the noise: he thinks it is one of the most wonderful films he has seen in years. Critics on Rotten Tomatoes gave it 32%. Audiences who are fans gave it 97%. Bruce says both are right depending on your relationship to the legacy. If you go in wanting the film to litigate Michael's guilt or innocence you will struggle, but if you go in for the music and the story you will be emotional and overwhelmed.See omnystudio.com/listener for privacy information.

Barbara Peters in conversation with Susan Isaacs

Brad Isaacs joined me to talk about the Dick Van Dyke Show; favorite episodes; writing a spec script for Taxi, handing it to Marilu Henner and her remembering twenty plus years later; sitcoms not talking down; Simpsons & Saul Bellow; mother could sing songs even though she hardly speak due to dementia; dropped out of high school and got a GED; goes to Vegas to be a pro gambler; watching DVD inspires him; gets a job on TBS series Safe at Home; leads to a freelance Head of the Class and a job at Webster; one Webster so bad guest actor Michael Richards walks off; freelance Duet; hired for Newharts last season; favorite episodes; Dan O'Shannon came up with shows ending; "Father Goose" episode with Henry Gibson; others being confused by which Newhart he worked on; getting hired at Roseanne; being asked to come up with a show for Tom Arnold; models it after DVD with Tom rarely seen; Roseanne wants more Tom Arnold, Brad quits; meeting Carl Reiner and getting forgiveness; writing to Bill Persky and getting a letter back from his 12 and 10 year old daughters; Ken Levine; meeting George McGovern on Newhart; Larry Sanders Show; Norm MacDonald story; rewriting Tommy Boy; adding Superstar and housekeeping among other things; NBC had high hopes for NewsRadio; shows were written by 4 writers; Dave Foley was young enough looking to me believable; episodes "Smoking" & "Big Day"; inspiring "Bitch Session"; quitting after a year; having the show down stairs "The John Larroquette Show" angry at them due to noise; not getting their due; working as a consultant on King of the Hill and Undeclared; writing 8 Crazy Nights and fighting with Sandler about poop jokes; creating Lovespring International, an improvised sitcom for Lifetime; Tarzana; A West Texas Children's Story

On this episode of Good Noise Podcast, I'm joined by Byron Isaacs and Peter Cole from Lost Leaders to talk about their single Atalanta. We dive into the storytelling behind the track, the inspiration that shaped it, and how the song fits into the band's overall sound and direction.Byron and Peter share insight into their songwriting process, the themes woven into Atalanta, and how they approach creating music that feels both intentional and emotionally resonant. We also talk about collaboration, lyrical depth, and what this release represents for Lost Leaders moving forward.Lost Leaders Socials:Instagram: https://www.instagram.com/lostleadersmusic/Facebook: https://www.facebook.com/lostleadersband/YouTube: https://www.youtube.com/@lostleadersApple Music: https://music.apple.com/us/artist/lost-leaders/428968338Spotify: https://open.spotify.com/artist/6AYs5B12k1aePGAUpkaZnv?si=4f321b5ec2954d13

Pastor John Nuzzo expounds on the concept of his book The Acceleration Mandate which is about the Abraham generation accelerating the Isaacs.  It's not just God turning the hearts of the fathers to the children, but the children turning their hearts back toward the fathers (Mal. 4:6).  When this happens, the Isaacs will gain access to the wisdom learned by an Abraham's lifelong experience and avoid unnecessary mistakes.  As a result of this relationship, Abrahams will live with great joy—empty hands but a full heart! Learn the steps to and the roadblocks of entering into a generational relationship.  There is an acceleration mandate on the earth right now.  Let us take our part, and it will come to pass!The Acceleration Mandate by Pastor John Nuzzo is available wherever books are sold, or click this link to order here  https://lifeatvictory.com/acceleration-mandate/. https://brushfire.com/lifeatvictory/encounterconference2026/615190/ticketsENCOUNTER CONFERENCE is a 3-day annual youth conference designed to create environments for believers to have an encounter with God so that our region is transformed for the Kingdom.  June 17 – 19, get your students, youth group, and children currently in grades 5-12 to Victory Family Church.  It will transform their lives, and they will have a blast doing it!  Only $39 per person through April 30.  Register here https://brushfire.com/lifeatvictory/encounterconference2026/615190/tickets

Drs. Isaacs and Traina discuss DESTINY-Breast09, where first‑line T‑DXd + pertuzumab clearly outperforms the CLEOPATRA regimen in progression-free survival for metastatic HER2+ breast cancer. They focus on the dilemma of when to use T‑DXd: earlier, for maximal efficacy, or later, to protect quality of life and manage ILD and cardiac risks.

On tonight's show, I'm joined by Dillan Isaacs, who was introduced to me through Jason Smith with Florida Springs Wellness & Recovery Center. Dillan shares his personal journey through struggle, what it took to reach a turning point, and how faith and the presence of the right people helped change his path. In the second segment, we talk about the work being done through Florida Springs and how they're helping others experience real healing through community, accountability, and purpose. There's a message in this conversation for anyone who has ever felt stuck, alone, or unsure of what's next.

In this continuation of Megan & Isaacs past life exploration, they dive deeper into the experiences that shaped the soul and mission of Isaac. From ancient Roman protector to secret guardian of a sacred bloodline, this episode reveals battles against dark forces, supernatural encounters, and the echoes of past life missions that continue to influence the present.Hear the full, unedited past life reading as it was channeled, and listen as they unpack how these experiences resonate in today's world. This episode is a bridge between the mystical and the modern, showing how past life patterns can illuminate our current path, purpose, and connection to the unseen.Get ready for dramatic revelations, supernatural encounters, and the threads that tie our soul's journey across lifetimes.Disclaimer: While some listeners may view the past life readings and interpretations in this episode as outlandish or unconventional, we present them as they were received. This episode is meant to explore experiences and perspectives that some may find extraordinary, and is shared for insight, reflection, and discussion. Interpretations of these readings are personal and meant to be considered within the context of our ongoing exploration of the paranormal and spiritual realms.

Helping absent students stay part of learning. About Simone Isaacs Simone Isaacs is the Director of Customer Success at No Isolation, where she works closely with schools across Europe to support the implementation of AV1, which is a telepresence robot. AV1 is a solution designed to maintain learning and belonging during student absence. With 28 years of experience in schools and alternative provisions, from classroom teacher to headteacher then working strategically in the local authority   Simone now focuses on helping schools develop structured, student-centred approaches to continuity, wellbeing, belonging and reintegration. LinkedIn: https://www.linkedin.com/in/simone-isaacs-ifip-81366454/ About Carina Schmitz Carina Schmitz works as Global Marketing Manager at No Isolation, the company behind AV1, a telepresence solution that helps children with long-term illness or school non-attendance stay connected to school and classmates. With an international background in marketing and communications, she works across European markets at the intersection of education, technology, and social impact. Carina is passionate about inclusive education and believes participation should never depend on physical presence. LinkedIn: https://www.linkedin.com/in/carina-schmitz-muc/ Resources AV1 for International Schools: https://www.noisolation.com/av1/av1-for-international-schools No Isolation (Company Website): https://www.noisolation.com  AV1 is a telepresence robot designed specifically for education. It helps international schools support students who are unable to attend in person due to illness, medical treatment, anxiety, relocation, or temporary distance. By enabling students to remain present in the classroom, both academically and socially, AV1 supports continuity of learning, wellbeing, and belonging until they are ready to return to campus.  John Mikton on Social Media LinkedIn: https://www.linkedin.com/in/jmikton/ Twitter: https://twitter.com/jmikton Web: beyonddigital.org Dan Taylor on social media: LinkedIn: https://www.linkedin.com/in/appsevents  Twitter: https://twitter.com/appdkt  Web: www.appsevents.com Listen on: iTunes / Podbean / Stitcher / Spotify / YouTube Do a full security audit of your Workspace for free at https://workspaceaudit.com Would you like to have a free 1 month trial of the new Google Workspace Plus (formerly G Suite Enterprise for Education)? Just fill out this form and we'll get you set up bit.ly/GSEFE-Trial

Guest: Al IsaacsEpisode SummaryWhat would you do if you discovered—after decades—that the story of your own life wasn't true? Would you want to know the truth?Comedian, writer, and performer Al Isaacs spent most of his life believing he knew exactly where he came from. But in his fifties, a stunning revelation surfaced: he had been adopted.That discovery set off a search for answers that would uncover hidden family connections, decades-old secrets, and the extraordinary realization that someone else had been searching for him for more than twenty years.In this episode, Al shares the emotional journey that followed—how the truth came to light, what it meant for his understanding of family and identity, and how the experience ultimately led him to write his memoir, Finding Mary Smith.This is a conversation about identity, family secrets, and the strange ways truth finds its way to the surface.In This Episode* The moment Al Isaacs discovered he had been adopted* Why adoption secrecy was so common in previous generations* The emotional complexity of searching for biological family* The surprising discovery that someone had been searching for him for decades* How humor and storytelling helped him process the experience* Why he ultimately turned the journey into a memoirAbout the GuestAl Isaacs is a writer, comedian, voice-over artist, and performer. After discovering later in life that he had been adopted, he began a search for his biological family that revealed a decades-long mystery. His memoir, Finding Mary Smith, tells the remarkable story of identity, family, and rediscovery.Resources & LinksAl Isaacs WebsiteBook: Finding Mary SmithPodcast InformationPodcast: Stories from Real Life, Media Well Done, LLCHost: Melvin E. EdwardsStories from Real Life features powerful true stories about the moments that shape who we become.Share This EpisodeIf this episode resonated with you, please consider:• Following the show• Leaving a review• Sharing the episode with someone who loves powerful true stories Get full access to Melvin E. Edwards at storiesfromreallife.substack.com/subscribe

Welcome back to When Words Fail, Music Speaks, the podcast that battles depression and everyday anxiety with the universal power of music. I'm your host, James Cox, and today we've got a truly special guest who embodies the ethos of our show: independent rocker‑songwriter Lee Isaacs.For the past four and a half years Lee has made Nashville his home, carving out a path that favors authenticity over industry labels. In this conversation he shares:Insider Nashville tips – from the bustling “Country Row” on Broadway to the hidden gems of Midtown (Live Oak, Tin Roof, Odie's) and his favorite food spots, including McDougal's hot chicken and Edley's BBQ.Songwriting stories – the spontaneous creation of “Runaway Romeo” during COVID, the narrative mystery behind “Spell on Me,” and the heartfelt tribute “Take Me Back to Lexington” that bridges his Kentucky roots with his Nashville life.The business side of being indie – why Lee founded his own publishing entity, Little Radical LLC, how he navigates self‑promotion, and the challenges and freedoms of running a solo label.Stagecraft and vulnerability – candid moments from his first Nashville gig, opening for Flo Rida, and the mental tricks musicians use to calm nerves before stepping on stage.Music as healing – the song U2's “Bad” that helped him through his dad's near‑fatal car accident, and his belief that music is “God's voice,” a language that connects us across languages, cultures, and generationsWhether you're a songwriter looking for inspiration, a budding indie artist curious about the business, or just someone who needs a reminder that music can mend the soul, this episode delivers raw honesty, practical advice, and a whole lot of heart.Grab your headphones, press play, and let Lee's story remind you why, when words fail, music always speaks.

Drs. Isaacs and Traina review how HER2CLIMB‑05 and PATINA challenge the old CLEOPATRA‑based approach by showing that adding tucatinib or palbociclib to maintenance therapy can extend progression‑free survival in metastatic HER2+ breast cancer. They stress tailoring maintenance regimens to each patient's hormone receptor status, CNS risk, and tolerance for side effects.

What would you do if the story of your life suddenly changed at age fifty-two? When Al Isaacs learned—almost accidentally—that he had been adopted through the “gray-market” adoption practices of the late 1960s, it set him on a journey through DNA testing, genealogy research, and long-buried family secrets that would ultimately reconnect him with his birth mother's story. In this episode: • The moment a doctor casually revealed the truth about Al's adoption • Why his parents' dementia made the search both urgent and complicated • The surprising clue that helped him find his birth mother, a folk singer named Mary Smith • How DNA testing is reshaping what “family secrets” even mean today • Why some late-discovery adoptees feel their identity shattered—and why Al experienced it differently • What people considering a search for their origins should understand before they begin Sometimes the truth doesn't arrive when we expect it—but when it finally does, it can change how we understand our entire story. Find Al and his memoir at https://www.alisaacs.com/ Learn more about Al and find all his links at https://boomwithabang.com/the-boomer-womans-podcast-al-isaacs/  

In this episode of Get Styled, Elsa sits down with intuitive life and leadership coach Madineyah Isaacs—one of the women who joined Elsa in Milan for the very first StyleCation experience.Madineyah shares the remarkable story of how she discovered her ability to read energy fields and help people clear the invisible blocks that keep them stuck. But the conversation goes far beyond intuition.Together, Elsa and Madineyah reflect on the deeper connection between inner alignment and how we show up in the world—our confidence, our presence, and even our personal style. They talk about what happens when you step outside your everyday environment and give yourself the space to reconnect with who you're becoming.Because sometimes the most powerful shifts don't happen through effort…They happen when you finally give yourself permission to listen to what you already know.If you'd like to join me in Milan this June, check out all the juicy details for the StyleCation experience in Milan here https://elsaisaac.com/stylecation-milan/.Madineyah Isaacs is an intuitive life and leadership coach whose work is as powerful as it is transformative. Madineyah has spent the last 16 years helping people across more than 80 nationalities clear energetic blocks, expand into their potential, and step into who they're truly meant to be. She reads energy the way most of us read words, with precision, compassion, and a deep understanding of what's possible when we stop getting in our own way. You can learn more about Madineyah here https://www.madineyah.com/.- - - - - - - - -If you liked this episode of the Get Styled Podcast, tell your friends! Find us on iTunes, Spotify, and just about anywhere you listen to podcasts. And please don't forget to rate/review/subscribe to the show - every little bit helps us be heard by those who need this message!- - - - - - - - -Want more? FIND ME at Elsaisaac.comFOLLOW ME on IG @elsaisaacSIGN UP FOR UPDATES about the podcast (and get access to my FREE Body Shape Calculator - the perfect tool to start you on your personal style journey)! Thanks for listening!- - - - - - - - -SHOW NOTES  0:46 - Elsa introduces Madineyah Isaacs and what we will be talking about today!2:36 - Madineyah explains the work that she does and how she got into it13:30 - Elsa asks Madineyah to discuss the intuitive energy clearing session they had together 20:41 - Madineyah details how her outer self is aligned with her inner self since working on her style (after a childhood of shopping for deals) - and divulges her reservations in working with a stylist34:35 - Madineyah recounts her Stylecation in Milan - and what made her take the plunge!42:58 - Madineyah discusses her transformation and intentionality and joy in Milan52:40 - Elsa and Madineyah discuss the power in choosing to let someone else take care of the details so one can “just” show up in their full power (as was done for the Milan experience)53:29 - Madineyah shares some last thoughts on being “thrown into the deep end of luxury” during the Milan experience as Elsa wraps up the episode 

We have a classic episode for you. Conquer prediabetes and diabetes prevention! We're joined by Dr. Scott Isaacs, who provides essential pearls on navigating  screening tests for diabetes and prediabetes, identifying atypical cases of prediabetes, and individualizing management of prediabetes with lifestyle changes and medications.Claim CME for this episode at curbsiders.vcuhealth.org!Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CMEShow Segments Intro Case from Kashlak Why screen for prediabetes and diabetes? Who to screen for prediabetes and diabetes How to screen for prediabetes and diabetes Role of the physical exam Explaining a diagnosis of prediabetes to patients Atypical types of prediabetes Management of prediabetes: lifestyle changes Management of prediabetes: medications Outro Credits Producer, Writer, and Show Notes: Malini Gandhi MD Infographic and Cover Art: Zoya Surani Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Sai Achi MD,MBA,FACP Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Scott Isaacs MD DisclosuresDr. Isaacs reports no relevant financial disclosures. The Curbsiders report no relevant financial disclosures. Sponsor: BabbelGet up to 60% off at Babbel.com/CURB. Sponsor: MedStudy QbankStudy less. Remember more. Pass confidently. Medstudy.com/Curbsiders CURB15 for 15% offSponsor: UPenn GSELearn more about our master's program, explore our certificate option, and sign up for an application fee waiver code. Take the next step in advancing medical education—visit www.gse.upenn.edu/curbsiders. Sponsor: LocumstoryWhether you're simply curious or seriously considering a change, pop by Locumstory.com to see if it's something that makes sense for you

Today, I'm joined by Zack Isaacs, founder & CEO of Movemint.   Movemint is an athletic events platform connecting participants, organizers, and brands through registrations, training integrations, and sponsorship marketplace.   In this episode, we discuss modernizing the event registration experience.   We also cover:   Events driving high-intent spending cycles Growing through Strava and Meta integrations Providing race sponsors with data and analytics   Subscribe to the podcast → insider.fitt.co/podcast  Subscribe to our newsletter → insider.fitt.co/subscribe  Follow us on LinkedIn → linkedin.com/company/fittinsider    Movemint's Website: www.movemint.cc  For Brands: https://www.movemint.cc/brands  For Organizers: https://www.movemint.cc/why_movemint    -   The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart fitness ecosystem for fitness and health facilities.   Fitt Talent: https://talent.fitt.co/  Consulting: https://consulting.fitt.co/  Investments: https://capital.fitt.co/    Chapters: (00:00) Introduction (01:08) Zack's background (02:10) Movemint's atomic unit (03:21) Legacy platform gaps and opportunities (04:30) High-intent spending cycles (05:12) Prioritizing organizers and brands (07:00) Movemint for Brands launch (08:05) Strava's community playbook (09:40) Small to large organizer evolution (11:15) NYC Marathon vs. tech-enabled events (12:01) Building community on other platforms first (13:20) Strava and Meta integrations (14:10) Training data driving event signups (15:10) Run club boom and COVID tailwinds (16:10) Design and UX differentiation (18:05) Olia Birulia: Strava Routes designer (19:25) Speed vs. quality (21:15) Hiring from network (23:25) Endurance athletes as employees (24:47) Movement for Brands (26:00) Brand sponsorship data and analytics (28:10) Race photography and brand tracking (29:10) Sponsorship marketplace mechanics (30:05) Gravel and road running focus (31:11) High Rocks and triathlon growth (32:00) $3.2M raised across pre-seed and seed (33:15) Strava's co-founder on board (34:00) Building profitable and enduring business (34:36) Conclusion  

Drs. Isaacs and Traina discuss new data in HER2+ breast cancer from the 2025 San Antonio Breast Cancer Symposium, focusing on early-stage studies including DESTINY-Breast11 and DESTINY-Breast05 and how data from these studies could potentially impact patient care in the future.

Rami Afif sits down with Royce Isaacs for their third conversation where the Mile High Samurai opens up about competing against Jon Moxley, traveling to Mexico for CMLL, plus much more. Please credit Rami Afif if you do use any quotes or clips from this interview. •Protect Your Connection Like a Champ With NordVPN!At Bodyslam.net, we know the importance of staying protected—whether you're in the ring or online. That's why we've partnered with NordVPN, the undisputed heavyweight champion of internet security, to bring our readers an exclusive deal.Unlock major savings and keep your data safe from hackers, trackers, and snooping ISPs—all while streaming wrestling content securely from anywhere in the world.Hit the link below to step into the ring with the best VPN in the business:

How do you scale a bold idea into a movement? In this HarmonyTALK podcast episode, host Lisa Champeau interviews Dakota Kate Isaacs, the first U.S. employee at DECIEM and former Director of DECIEM USA. Dakota helped grow The Ordinary into one of the most disruptive beauty brands in the world, expanding to more than 2,500 retail locations across North America. She discusses scaling disruption, working alongside founder Brandon Truaxe, executive producing the documentary The Abnormal Beauty Company, and launching The Big Sister Playbook, a podcast and field guide for modern ambition. Perfect for entrepreneurs, marketers, founders, and emerging leaders, this episode delivers real-world leadership insight and inspiration. FOLLOW HARMONYTALK PODCAST @harmonytalkpodcast Join Our Mailing List: https://www.harmonytalkpodcast.com/signup Instagram: https://instagram.com/harmonytalkpodcast Facebook: https://www.facebook.com/harmonytalkpodcast YouTube: https://youtube.com/@HarmonyTALKPodcast LinkedIn: https://www.linkedin.com/company/harmonytalkpodcast https://harmonytalkpodcast.com/ Follow Host, Lisa Champeau: https://www.instagram.com/lisachampeau/ Email harmonytalkpodcast@gmail.com for sponsorship and guest opportunities! See omnystudio.com/listener for privacy information.

Welcome to Chatterbox - a bite-sized taster of Josh Smith's Great Chat Show. Josh dives into a round of conversation starters. Quick questions. Instinctive answers. Real, honest chat. We're throwing it back to our very first episode with Jason Isaacs. From Lucius Malfoy to a darkly unforgettable Captain Hook, Isaacs has built an iconic career playing characters you love to hate - most recently earning a Golden Globe nomination for The White Lotus. In this chat, he opens up about why silence can be more powerful than words, why he's always been drawn to questioning authority - and whether he feels even slightly guilty about pushing Dobby down the stairs. Learn more about your ad choices. Visit podcastchoices.com/adchoices

This week, Danielle and Kristine learn how to survive the loss of a body part and Macey Isaacs joins us to share the time she lost her front teeth!

Comedian Macey Isaacs | The Brett Allan Show www.brettallan.com for more. Originally from Austin, Macey studied The Groundlings and is a nationally touring stand-up comedian. She has performed in festivals including Netflix Is a Joke, Laughing Skull, Flyover, Limestone, Boston Comedy Fest, PRIZE, and Bergamot and has been featured on Netflix is a Joke Radio on Sirius XM. She's opened for comedians such as Tom Segura, Dusty Slay, Dean Delray, and Shane Torres.   In Santa Monica, she hosts "The Picture Day Show", a popular stand-up comedy showcase at The Crow. Macey also co-hosts the mental health and comedy podcast SSRI'M OK with Dr. Bijan Zarrabi, where they navigate discussions about mental health topics with expert guests and comedians. ​ In 2001, she was the Knights of Columbus Free Throw Champion at her elementary school. In 2022, she was named one of Interrobang's "Top 35 Comics to Break Out," and in 2023, she was a finalist in KTLA's Summer of Funny. In 2025, she made her network television debut on Comics Unleashed on CBS, and released her Don't Tell Comedy special "How I Lost My Teeth" and her Dry Bar Comedy special "Half Sister." Learn more about your ad choices. Visit megaphone.fm/adchoices

“Keep being creative... continue to pursue whatever your passion is.” - Lee Isaacs A Song of Life: Sit down with Nashville-based singer-songwriter Lee Isaacs for an honest and wide-ranging conversation about creativity, storytelling, and building a life in music on his own terms. From his roots as a writer to discovering songwriting as a way to compress entire emotional narratives into just a few minutes, Lee reflects on the artists, moments, and quiet observations; sunsets, stillness, and everyday life, that continue to shape his sound. Jim and Lee dive into the realities of being an independent artist today: blending genres without chasing trends, using video and social platforms as creative tools, protecting your work through ownership and publishing, and finding success by simply refusing to give up. This episode is a grounded, inspiring look at what it really takes to stay curious, stay honest, and keep creating in a noisy world. images/video: ©lee isaacs – used with permission lee isaacs website lee isaacs instagram Subscribe: iTunes | Android | Spotify | Email | RSS MORE ART UNKNOWN PODCASTS

Send us a textIn this episode, we are joined by Cheryl Boone Isaacs, a former Pan Am stewardess from 1972 to 1974 who went on to build an extraordinary career in Hollywood. Her journey is a remarkable one that spans aviation, Hollywood, and film education. She began her professional career as a Pan Am stewardess from 1972 to 1974, an experience that gave her a global perspective and a deep appreciation for storytelling and human connection.After leaving Pan Am, Cheryl moved to San Franscico where she held various jobs. However, she always thought about either going back into aviation or pursuing her dream of being in the film business inspired in part by her brother, Ashley Boone, a pioneering film executive. Learn more about Ashley here: https://www.hollywoodreporter.com/movies/movie-features/he-was-star-wars-secret-weapon-why-was-he-forgotten-1275211/Through him, she attended an advanced screening of Star Wars before its release in May 1977. That moment proved transformational and solidified her belief that the motion picture industry was where she belonged. So, she packed her bags and moved to Hollywood. Over the decades that followed, Cheryl worked on the marketing, publicity, and release of some of the most iconic films in cinema history. Her credits include Forrest Gump, Titanic, The King's Speech, Braveheart, The Artist, Close Encounters of the Third Kind, The Right Stuff, Once Upon a Time in America, The Wedding Singer, Austin Powers: The Spy Who Shagged Me, and Spider-Man 2. She also worked on two Indiana Jones films and five Star Trek films.Behind the scenes, Cheryl broke significant barriers. She became the first African American woman to lead a major studio marketing department at New Line Cinema, and later the first African American to serve as President of the Academy of Motion Picture Arts and Sciences, where she guided the organization through a pivotal period of reflection and change.Today, she continues shaping the future of storytelling as the Founding Director and Professor of Practice at the Sidney Poitier New American Film School at Arizona State University (film.asu.edu). In that role, she mentors students and builds a program grounded in Sidney Poitier's legacy, emphasizing inclusion, leadership, and real-world industry experience.From the skies of Pan Am to Hollywood studios and now the classroom, Cheryl Boone Isaacs' career reflects a lifelong commitment to storytelling, leadership, and opening doors for future generations. Support the show Visit Us for more Pan Am History! Support the Podcast! Donate to the Museum! Visit The Hangar online store for Pan Am gear! Become a Member! Follow us on Facebook, Instagram, and Twitter!A very special thanks to Mr. Adam Aron, Chairman and CEO of AMC and president of the Pan Am Historical Foundation and Pan Am Brands for their continued and unwavering support!

Jimmy wonders which dead rock stars would join forces to create the ultimate super group in heaven. Then, we get to know Macey and find out which "off limits" word proved the most challenging for her when recording a completely clean stand-up set for Dry Bar.If you'd like a second full episode every week, plus video of every episode and monthly bonuses, head over to nevernotfunny.com and sign up for a Platinum subscription. Plans start at $6/month and more perks, like access to our back catalog and game nights on Zoom, are also available. Sign up today!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Adam Yenser is a stand-up comedian. He's currently on tour with dates at The Emmaus Theatre in Pennsylvania on Dec 26 and Caesar's Republic in Lake Tahoe, CA from Jan 2–4. Check out his YouTube show The Cancelled News, and follow him on Instagram @adamyenser and on X @cleancomedian69.Macey Isaacs is a stand-up comedian. Her special Half Sister is available now exclusively at drybarcomedy.com. Find more at maceyisaacs.com and follow her on Instagram @maceyisaacs.IN THE NEWS: A Cinnabon worker in Wisconsin was fired after video surfaced of her hurling racist slurs at two customers, prompting swift backlash and a public statement from the company condemning the incident. Ben Stiller, Simu Liu, Alec Baldwin, and others are rallying around Paul Dano after Quentin Tarantino slammed him as the “weakest male actor” and a “non-entity” in There Will Be Blood, sparking a wider debate about harsh director criticism. Meanwhile, Bill Maher and Ana Kasparian got into a fiery on-air clash over Islam and the Middle East, with Maher pressing her to name a Muslim-majority city she'd rather live in than Tel Aviv as they battled over religion, culture, and blame.Get it on!Subscribe to The Adam Carolla Show on Substack: https://adamcarolla.substack.com/FOR MORE WITH ADAM YENSER:TOUR: Dec 26 - The Emmaus Theatre - PA Jan 2-4 - Caesar's Republic - Lake Tahoe CA YOUTUBE SHOW: The Cancelled NewsINSTAGRAM: @adamyenser TWITTER: @cleancomedian69 FOR MORE WITH MACEY ISAACS:SPECIAL: Half SisterAvailable Now exclusively on Dry BarINSTAGRAM: @maceyisaacsWEBSITE: maceyisaacs.comFOR MORE WITH JASON “MAYHEM” MILLER: INSTAGRAM & TWITTER: @mayhemmillerWEBSITE: www.mayhemnow.comLIVE SHOWS: December 11 - Fort Lauderdale, FLDecember 12 - Miami, FL (2 shows)December 13 - Miami, FL (2 shows)December 14 - Fort Lauderdale, FLThank you for supporting our sponsors:BetOnline​Exclusive $35 off Carver Mat at https://on.auraframes.com/CAROLLA. Promo Code CAROLLALive Better Longer with BUBS Naturals. For A limited time get 20% Off your entire order with code Adam at Bubsnaturals.comHomes.comForThePeople.com/Adamoreillyauto.com/ADAMpluto.tvSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.